Loading insider details...
Beta
Latest Form 4 (Sep 21, 2026): Exercise/Conversion of 30,000 CRSP shares, $420.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 30,000 | $420.0K |
| Sep 21, 2026 | CRISPR Therapeutics AG (CRSP) | Other (see footnotes) | 60 | n/a |
| Sep 21, 2026 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 7,707 | $14.9K |
| Jul 6, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Other (see footnotes) | 1,000,000 | n/a |
| Jun 29, 2026 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 40,000 | n/a |
| Jun 22, 2026 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 8,961 | $14.9K |
| Jun 12, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 25,800 | n/a |
| Jun 11, 2026 | Korro Bio, Inc. (KRRO) | Grant/Award | 14,677 | n/a |
| Jun 11, 2026 | Nkarta, Inc. (NKTX) | Grant/Award | 37,000 | n/a |
| Jun 9, 2026 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 13,000 | n/a |